Stock Research: Camurus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Camurus

OM:CAMX SE0007692850
58
  • Value
    82
  • Growth
    81
  • Safety
    Safety
    3
  • Combined
    60
  • Sentiment
    57
  • 360° View
    360° View
    58
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Camurus AB is a Sweden-based pharmaceutical and biotechnology company focused on specialty medicines for severe and chronic diseases. They operate in the pharmaceutical and biotechnology industries, developing products for opioid dependence, pain, cancer, and endocrine diseases. The company is based in Sweden and has legal entities in the US, Germany, UK, Finland, Norway, France, Australia, Spain, Denmark, Austria, and the Netherlands. In the last fiscal year, the company had a market cap of $4186 million, profits of $157 million, revenue of $169 million, and 256 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 58 (better than 58% compared with alternatives), overall professional sentiment and financial characteristics for the stock Camurus are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Camurus. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 81% of competitors in the same industry. The consolidated Safety Rank at 82 means that the company has a financing structure that is safer than 82% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 57, which means that professional investors are more optimistic about the stock than for 57% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 3, meaning that the share price of Camurus is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 97% of alternative stocks in the same industry. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 4 1 8
Growth
81 100 95 91
Safety
Safety
82 96 80 34
Sentiment
57 54 76 82
360° View
360° View
58 57 86 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
82 69 78 95
Opinions Change
57 50 72 50
Pro Holdings
n/a 45 53 64
Market Pulse
40 48 39 31
Sentiment
57 54 76 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 4 1 8
Growth
81 100 95 91
Safety Safety
82 96 80 34
Combined
60 69 72 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
16 14 6 25
Price vs. Earnings (P/E)
3 3 5 31
Price vs. Book (P/B)
1 3 5 12
Dividend Yield
1 1 1 1
Value
3 4 1 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
87 96 73 90
Profit Growth
98 98 100 78
Capital Growth
74 85 22 93
Stock Returns
41 86 100 20
Growth
81 100 95 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
90 92 90 77
Refinancing
43 25 27 36
Liquidity
92 100 79 8
Safety Safety
82 96 80 34

Similar Stocks

Discover high‑ranked alternatives to Camurus and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

SKF

OM:SKF B
Country: Sweden
Industry: Industrial Machinery
Size: Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.